Published in
Impact Journals, Oncotarget, 30(8), p. 48737-48754, 2017
DOI: 10.18632/oncotarget.17114
Links
- ORCID
- ORCID
- Impact Journals
- [ueaeprints.uea.ac.uk] | PDF
- [eprints.soton.ac.uk] | PDF
- [spiral.imperial.ac.uk] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis
Journal article published in 2017 by
Franco Conforti,
Elizabeth R. Davies,
Claire J. Calderwood,
Thomas H. Thatcher,
Mark G. Jones,
David E. Smart 
,
Sumeet Mahajan ,
Aiman Alzetani,
Tom Havelock,
Toby M. Maher,
Philip L. Molyneaux,
Andrew J. Thorley,
Teresa D. Tetley,
Jane A. Warner,
Graham Packham
and other authors.
,
Sumeet Mahajan ,
Aiman Alzetani,
Tom Havelock,
Toby M. Maher,
Philip L. Molyneaux,
Andrew J. Thorley,
Teresa D. Tetley,
Jane A. Warner,
Graham Packham
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 